The fees the U.S. Food and Drug Administration charges medical device manufacturers under the Medical Device User Fee program are slated to slightly drop in fiscal year 2015, according to a notice in the Federal Register.
Supply Chain
AstraZeneca announced an agreement to pay up to $2.1 billion to purchase Spanish pharmaceutical Almirall's respiratory drug portfolio.
FedEx pleaded not guilty to charges that the company illegally delivered controlled substances and prescription from online pharmacies to U.S. consumers without valid prescriptions, according to a report in The Wall Street Journal.
The drug Sovaldi, manufactured by Foster City, Calif.-based Gilead Sciences, has garnered a lot of attention for its hefty price tag, coming in at $1,000 per pill, or up to $84,000 for a full course of hepatitis C treatment.
In a letter to the editor in Lasers in Surgery and Medicine, Brian Biesman, MD, director of the Nashville (Tenn.) Centre for Laser and Facial Surgery, and Neelam Patel of Vanderbilt University School of Medicine in Nashville, alert physicians to…
The time to market for medical devices can be a lengthy commercialization process, but 3-D printing may help quicken the timeline, according to a Plastics Today report.
A group of 26 physician organizations wrote to CMS asking for further clarification and context regarding upcoming public reporting of data showing how much drug makers pay physicians.
Charlotte, N.C.-based Premier sent a letter to the chairmen and ranking members on the Finance and Ways and Means Committees voicing its support for the Improving Medicare Post-Acute Care Transformation Act of 2014.
Irving, Texas-based Novation has named Mundelein, Ill.-based Medline the 2013 Medical Supplier of the Year.
The U.S. Attorney for the Northern District of California has charged FedEx for allegedly knowingly distributing controlled substances and prescription drugs to consumers in the U.S. who do not have a valid prescription, according to a news release from the…